UnannouncedVCInvestor

WHIN

Startup rounds since 2015 with a WHIN investor on the board, and the firm's own fund filings.

Raises
17
since 2015
Unannounced
3
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name

Rounds

  1. Episteme Prognostics, Inc.$5.09MUnannounced · 12 days4 Sep 2026 · Brooklyn, NY · Biotech
  2. Allyx Therapeutics, Inc.$26.4MAnnounced 36 days later11 May 2026 · New Haven, CT · Biotech
  3. Allyx Therapeutics, Inc.$3.32MUnannounced · 197 days3 Mar 2026 · New Haven, CT · Biotech
  4. Episteme Prognostics, Inc.$550KUnannounced · 555 days10 Mar 2025 · Brooklyn, NY · Biotech
  5. Episteme Prognostics, Inc.$4.11MFiled before 202522 May 2023 · New York, NY · Biotech
  6. Allyx Therapeutics, Inc.$2.31MFiled before 202510 Feb 2023 · New Haven, CT · Biotech
  7. AtlasXomics Inc.$3.9MFiled before 20256 Jan 2022 · New Haven, CT · Biotech
  8. Allyx Therapeutics, Inc.$7.58MFiled before 20252 Jun 2021 · New Haven, CT · Biotech
  9. AtlasXomics Inc.$1.79MFiled before 20259 Mar 2021 · New Haven, CT · Biotech
  10. IsoPlexis Corp$7.5MFiled before 20258 Jan 2021 · Branford, CT · Technology
  11. IsoPlexis Corp$85MFiled before 20258 Jan 2021 · Branford, CT · Technology
  12. ReNetX Bio, Inc.$2.8MFiled before 202528 Sep 2020 · New Haven, CT · Biotech
  13. AtlasXomics Inc.$470KFiled before 20253 Jun 2020 · New Haven, CT · Biotech
  14. IsoPlexis Corp$19.6MFiled before 202514 Nov 2018 · Branford, CT · Technology
  15. IsoPlexis Corp$5.4MFiled before 202510 Aug 2017 · Branford, CT · Technology
  16. IsoPlexis Corp$5.75MFiled before 202529 Jun 2016 · Branford, CT · Technology
  17. IsoPlexis Corp$2.35MFiled before 202529 May 2015 · New Haven, CT · Technology

By year

YearRaisesUnannounced
202632
202511
20232
20221
20214
20202
20181
20171
20161
20151

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
WHIN Opportunity Fund, LP23 Sep 2025Open-ended$11.9M
WHIN Opportunity Fund, LP25 Sep 2024Open-ended$11.9M

Listed because a WHIN fund's filing names a director of each company. A name match is not a verified identity.